FDA.reportPublic FDA data

POLYETHYLENE GLYCOL 400

Substance profile for UNII B697894SGQ, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for POLYETHYLENE GLYCOL 400
Structure render from NCI/CADD chemical resolver

Substance Identity#

UNII
B697894SGQ
Preferred term
POLYETHYLENE GLYCOL 400
Registry number
25322-68-3
EC number
225-856-4
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Polymer substance not supported
Chemical structure for POLYETHYLENE GLYCOL 400
Structure render from NCI/CADD chemical resolver

Chemical And Database Identifiers#

RxCUI
8514
PubChem
0
NCIt
C84080
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm8514https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=8514
NCI ThesaurusC84080https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C84080
FDA Substance Registration SystemB697894SGQhttps://precision.fda.gov/uniisearch/srs/unii/B697894SGQ
European Community number225-856-4https://commonchemistry.cas.org/results?q=225-856-4

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
Polyethylene Glycol 400INACTIVE INGREDIENTB697894SGQSpecial Clearing Booster2
polyethylene glycol 400INACTIVE INGREDIENTB697894SGQThese highlights do not include all the information needed to use ciprofloxacin safely and effectively. See full prescribing information for ciprofloxacin. CIPROFLOXACIN tablets USP, for oral use Initial U.S. Approval: 19871
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQNAPROXEN Tablets, USP NAPROXEN SODIUM Tablets, USP1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQCYCLOBENZAPRINE HYDROCHLORIDE4
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQDOCUSATE SODIUM AND SENNA2
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQ23e6429e-7c6c-4391-e054-00144ff88e881
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQDoc2
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQCEFUROXIME AXETIL2
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQDrug Facts1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQDrug Facts1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQCYCLOBENZAPRINE HYDROCHLORIDE5
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQThese highlights do not include all the information needed to use topiramate tablets, USP safely and effectively. See full prescribing information for topiramate tablets, USPTopiramate Tablets, USP for oral use Initial U.S. Approval: 19965
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQMUPIROCIN1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQTOPIRAMATE1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQDrug Facts2
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQLDO Plus (Lidocaine HCl USP) 4%1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQMetformin Hydrochloride Tablets USP Rx Only3
POLYETHYLENE GLYCOL 400ACTIVE MOIETYB697894SGQ748f6c30-a2ac-46be-9a31-5a37ecfa79262
POLYETHYLENE GLYCOL 400ACTIVE INGREDIENTB697894SGQ748f6c30-a2ac-46be-9a31-5a37ecfa79262
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQTOPIRAMATE6
Polyethylene Glycol 400INACTIVE INGREDIENTB697894SGQL-Methyl-MC Tablets3
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQMUPIROCIN OINTMENT USP, 2% 1010 For Dermatologic Use Rx only1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQThese highlights do not include all the information needed to use levofloxacin tablets safely and effectively. See full prescribing information for levofloxacin tablets. LEVOFLOXACIN Tablet, Film Coated for Oral use Initial U.S. Approval: 19969
polyethylene glycol 400INACTIVE INGREDIENTB697894SGQSheltered Broad Spectrum Sunscreen SPF 551
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQBlistex ® Enhancement Series ® (Soft and Lush ® , Deep Renewal ® and Ultra-Rich Hydration ® )1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQNABUMETONE2
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQESCITALOPRAM OXALATE6
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQESZOPICLONE2
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQLEVOFLOXACIN3
POLYETHYLENE GLYCOL 400ACTIVE INGREDIENTB697894SGQ1b02a39e-1960-2ca6-e054-00144ff8d46c1
POLYETHYLENE GLYCOL 400ACTIVE MOIETYB697894SGQ1b02a39e-1960-2ca6-e054-00144ff8d46c1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQDrug Facts1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQThese highlights do not include all the information needed to use LEVOCETIRIZINE dihydrochloride tablets safely and effectively. See full prescribing information for LEVOCETIRIZINE dihydrochloride tablets. LEVOCETIRIZINE dihydrochloride tablets for oral use Initial U.S. Approval: 19957
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQTOPIRAMATE- topiramate tablet1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQNeuro Max Pain and Muscle Relief Gel6
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQThese highlights do not include all the information needed to use galantamine hydrobromide safely and effectively. See full prescribing information for Galantamine Hydrobromide Tablets, USP. Galantamine Hydrobromide Tablets, USP for oral use Initial U.S. Approval: 20011
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQRx only4
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQThese highlights do not include all the information needed to use atovaquone and proguanil hydrochloride tablets safely and effectively. See full prescribing information for atovaquone and proguanil hydrochloride tablets . ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS, for oral administration Initial U.S. Approval: 20001
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQCitalopram Tablets USP, film-coated Rx Only4
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQd49b5b7f-59af-40c5-a0ec-79f5bf8aa56c1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQDrug Facts1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQBlistex ® Soft and Lush ®1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQmetoprolol tartrate tablets, USP1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQMETOPROLOL TARTRATE TABLETS USP 0733 07341
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQDRUG FACTS1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQ118054c8-1a22-324b-e054-00144ff8d46c1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQMETFORMIN HYDROCHLORIDE TABLETS USP, 500 mg, 850 mg, and 1000 mg 1048 1049 7214 Rx only2
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQMETFORMIN HYDROCHLORIDE TABLETS USP, 500 mg, 850 mg, and 1000 mg 1048 1049 7214 Rx only1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQPenicillin V Potassium Tablets, USP Rx only1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQVerapamil Hydrochloride Extended-Release Tablets, USP1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQ7da354c6-aec2-4934-984f-1e70190ccb0e2
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQCitalopram Hydrobromide Tablets, USP1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQ53f2d684-64f8-47de-9e24-41539e4a69542
POLYETHYLENE GLYCOL 400ACTIVE MOIETYB697894SGQ6fe0e844-268e-42d7-bc98-57b4f001911b1
POLYETHYLENE GLYCOL 400ACTIVE INGREDIENTB697894SGQ6fe0e844-268e-42d7-bc98-57b4f001911b1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQVerapamil Hydrochloride Tablets USP Revised: January 2014 Rx only1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQThese highlights do not include all the information needed to use carvedilol safely and effectively.See full prescribing information for carvedilol. Carvedilol Tablets, USP Initial U.S. Approval: 19951
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQMETFORMIN HYDROCHLORIDE tablet1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQNASAL SPRAY - ORIGINAL 15mL and 30mL2
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQThese highlights do not include all the information needed to use escitalopram tablets safely and effectively. See full prescribing information for escitalopram tablets. Escitalopram Tablets USP, for oral use Initial U.S. Approval: 20021
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQMetformin Hydrochloride Tablets USP Rx Only1
Polyethylene Glycol 400INACTIVE INGREDIENTB697894SGQThese highlights do not include all the information needed to use Topiramate Tablets USP safely and effectively. See full prescribing information for Topiramate Tablets USP. OPIRAMATE Tablets USP for oral use Initial U.S. Approval: 19961
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQDrug Facts2
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQ0fbb189e-62f3-d9bb-cd48-d88e0648eb502
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQBlistex Baby Kanka ® Gel1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQDrug Facts2
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQThese highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets USP safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets USP. PANTOPRAZOLE Sodium delayed-release tablets USP for oral use Initial U.S. approval: 20001
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQPleasure Balm9
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQDRUG FACTS1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQDRUG FACTS1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQDRUG FACTS1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQDRUG FACTS1
POLYETHYLENE GLYCOL 400ACTIVE MOIETYB697894SGQ48347e88-ce20-4b44-9f72-0282b0e653a01
POLYETHYLENE GLYCOL 400ACTIVE INGREDIENTB697894SGQ48347e88-ce20-4b44-9f72-0282b0e653a01
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQRegular Strength Enteric Anti-inflammatory/Analgesic Aspirin1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQThese highlights do not include all the information needed to use clopidogrel tablets safely and effectively. See full prescribing information for clopidogrel tablets. Clopidogrel Tablets USP for oral use Initial U.S. Approval: 19971
POLYETHYLENE GLYCOL 400ACTIVE MOIETYB697894SGQd1b30723-e2b1-4772-a11e-57ba9acc93432
POLYETHYLENE GLYCOL 400ACTIVE INGREDIENTB697894SGQd1b30723-e2b1-4772-a11e-57ba9acc93432
POLYETHYLENE GLYCOL 400ACTIVE INGREDIENTB697894SGQa9bdb9b3-51fb-453d-9961-3babdf4b65451
POLYETHYLENE GLYCOL 400ACTIVE MOIETYB697894SGQa9bdb9b3-51fb-453d-9961-3babdf4b65451
POLYETHYLENE GLYCOL 400ACTIVE MOIETYB697894SGQ9bcdd044-e3b4-4f8c-89d5-b0db33767f9d4
POLYETHYLENE GLYCOL 400ACTIVE INGREDIENTB697894SGQ9bcdd044-e3b4-4f8c-89d5-b0db33767f9d4
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQDrug Facts1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQVENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES USP 7384 7385 7386 Rx only7
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQedf29e02-f3db-4954-9a1a-9f153f9a073f2
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQ3e5f87be-78d9-4501-8f8b-566a8684727a1
POLYETHYLENE GLYCOL 400ACTIVE INGREDIENTB697894SGQ8d6f13bb-0fb6-4e66-8a8b-72612d3aacf25
POLYETHYLENE GLYCOL 400ACTIVE MOIETYB697894SGQ8d6f13bb-0fb6-4e66-8a8b-72612d3aacf25
POLYETHYLENE GLYCOL 400ACTIVE MOIETYB697894SGQ138b8a7c-99f5-45e6-a81b-fbb211e1c99d2
POLYETHYLENE GLYCOL 400ACTIVE INGREDIENTB697894SGQ138b8a7c-99f5-45e6-a81b-fbb211e1c99d2
Polyethylene Glycol 400INACTIVE INGREDIENTB697894SGQ7c7dbac3-dd9e-d03a-1303-3d2a207c751b3
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQLidonexe Patch1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQPure-Aid NIGHTTIME SLEEP-AID1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQThese highlights do not include all the information needed to use duloxetine delayed-release capsules, USP safely and effectively. See full prescribing information for duloxetine delayed-release capsules, USP. DULOXETINE delayed-release capsules USP, for oral use. Initial U.S. Approval: 20042
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQFamily Wellness1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQb4189b86-b109-4828-9bcb-38e9dbc248db1
POLYETHYLENE GLYCOL 400ACTIVE INGREDIENTB697894SGQ46288fea-f448-4a9e-b3da-f9fc54614ffd1
POLYETHYLENE GLYCOL 400ACTIVE MOIETYB697894SGQ46288fea-f448-4a9e-b3da-f9fc54614ffd1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQRevised: August 2014 Mirtazapine Tablets, USP Rx only2
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQDrug Facts1
POLYETHYLENE GLYCOL 400ACTIVE MOIETYB697894SGQ77a8ae01-61ad-4c40-a493-f98c2d29bf811
POLYETHYLENE GLYCOL 400ACTIVE INGREDIENTB697894SGQ77a8ae01-61ad-4c40-a493-f98c2d29bf811
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQThese highlights do not include all the information needed to use carvedilol safely and effectively. See full prescribing information for carvedilol tablets, USP. Carvedilol Tablets, USP Initial U.S. Approval: 19951001
POLYETHYLENE GLYCOL 400ACTIVE INGREDIENTB697894SGQ56862988-2b5e-4510-b46d-d2325ffefe191
POLYETHYLENE GLYCOL 400ACTIVE MOIETYB697894SGQ56862988-2b5e-4510-b46d-d2325ffefe191
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQf1f051d8-b8d8-4afd-84d8-82a59d9fa4fb1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQChildrens Nortemp1
polyethylene glycol 400INACTIVE INGREDIENTB697894SGQ2666b95e-667f-471a-9929-9deca27e9cbc2
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQDRUG FACTS1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQ81a4cf27-585b-484b-b0d8-4e21b40164181
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQThese highlights do not include all the information needed to use metoprolol succinate extended-release tablets USP safely and effectively. See full prescribing information for metoprolol succinate extended release tablets USP. Metoprolol succinate extended-release tablets USP Initial U.S. Approval: 19921
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQSertraline Tablets, USP 50 mg Iss. 09/12 Rx Only3
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQDove Sensitive Skin Antiperspirant deodorant2
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQDove Fresh Antiperspirant deodorant2
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQDove Powder Antiperspirant deodorant2
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQb32fcb1b-fee4-44b8-a91c-10dfdd3f84ea3
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQThese highlights do not include all the information needed to use levofloxacin tablets safely and effectively. See full prescribing information for levofloxacin tablets. LEVOFLOXACIN Tablet, Film Coated for Oral use Initial U.S. Approval: 19967
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQCitalopram Tablets, USP Rx Only5
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQDrug Facts1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQDRUG FACTS1